This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Health Care Vote Critical to Coming Week

Updated from 6:00 p.m. EST

Updated to include House passage of health care reform legislation.

NEW YORK ( TheStreet) -- Investors may be suffering from health care fatigue, but the short-term direction of the stock market in the coming week was seen hinging on Sunday's vote.

The House of Representatives Sunday night passed the landmark, $940 billion health care overhaul.

Passage was secured after President Obama and House Democratic leaders worked out a last-minute deal with antiabortion Democrats who had voiced opposition to the bill. The president appeased the group by issuing an executive order offering assurances that no federal money would be used for elective abortions.

The latest version of the bill includes a handful of new taxes for investors on interest, dividends and capital gains in order to pay for the health care expansion.

> > Bull or Bear? Vote in Our Poll

Market observers argued that with a relatively light slate of economic and earnings releases, the market would take its biggest cue from the outcome of the vote.

"If the House does vote on this, it will be a dissection of what it all means to the market," said Jay Suskind, senior vice president with Duncan-Williams. "We have the stealth capital gains taxes and what it will do to investing, the market's recent quiet rally, and health care stocks."

Robert Pavlik, chief market strategist with Banyan Partners, said that passage of the bill would likely garner a negative reaction from the market due to headlines over the capital gains tax, although he argued that wise investors should view any pullback as a short-term one that provides a good entry point.

"The health care bill and the capital gains tax news is more of the same noise that Wall Street shouldn't have to deal with," Pavlik said. "Personally, I'd be more concerned on the economy improving than an increase in capital gains. Focus on the longer-term trends, rather than the short-term Street noise."

In addition, Pavlik called the latest version of the bill "watered down," which leads him to believe that health care stocks like Aetna (AET - Get Report), Cigna (CI) and Humana (HUM - Get Report) won't see a big move whether the bill is passed or not.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.42 -27.13 -1.34%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs